Sydnexis is decreasing myopic progression in children.

A novel, stable, & comfortable topical eyedrop used once daily at bedtime.

A Phase 3 study to treat the progression of myopia in children.

Learn more about Myopia & how to treat it.

See more at ClinicalTrials.gov.

May 15, 2021

Financing Led by Visionary Ventures and Bluestem Capital

August 10, 2021